Back to Resource Center

Clinical Trials Begin on Antibody-based Prevention of HIV and Genital Herpes: Leaf Bio’s MB66 Developed as Multipurpose Prevention Technology

Clinical Trials Begin on Antibody-based Prevention of HIV and Genital Herpes: Leaf Bio’s MB66 Developed as Multipurpose Prevention Technology

January 2016

Click to view Press Release

Click for full info +

Clinical Trials Begin on Antibody-based Prevention of HIV and Genital Herpes: Leaf Bio’s MB66 Developed as Multipurpose Prevention Technology

Clinical Trials Begin on Antibody-based Prevention of HIV and Genital Herpes: Leaf Bio's MB66 Developed as Multipurpose Prevention Technology
07 January 2016
click to view Press Release
In this Press Release:
Health Risk(s):

  • HIV
  • STI / STD
    • Product Type(s):

  • MPTs
    • Topic(s):

  • MPTs
  • Product Development
  • Product Trials
  • Reproductive Health


    • Full Info:


    Resource Type:

    Press Release

    Citation:

    (2016, January 7).  LeafBio. Mapp Biopharmaceutical.

    Authors:

    [No authors listed]

    Health Risks(s):

    • HIV
    • STI / STD

    Product type(s):

    • MPTs

    Topic(s):

    • MPTs
    • Development
    • Trials
    • Reproductive Health

        URL of resource:

        http://mappbio.com/clinical-trials-begin-on-antibody-based-prevention-of-hiv-and-genital-herpes/

        Back to Resource Center